Impromidine
From Wikipedia, the free encyclopedia
 |
|
|
Impromidine
|
|
| Systematic (IUPAC) name | |
| N-[3-(imidazol-4-yl)-propyl]-N'-{2-[(5-methylimidazol- 4-yl)methylthio]ethyl}-guanidine |
|
| Identifiers | |
| CAS number | |
| ATC code | ? |
| PubChem | |
| Chemical data | |
| Formula | C14H23N7S |
| Mol. mass | 321.44 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Impromidine (INN) is a highly potent and specific histamine H2 receptor agonist. [1]
It has been used diagnostically as a gastric secretion indicator.
See Histamine agonists.
[edit] References
- ^ Durant G, Duncan W, Ganellin C, Parsons M, Blakemore R, Rasmussen A (1978). "Impromidine (SK&F 92676) is a very potent and specific agonist for histamine H2 receptors". Nature 276 (5686): 403–5. doi:. PMID 714166.
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
